Singulex abandons IPO amid economic gloom
This article was originally published in Clinica
Executive Summary
Diagnostic firm Singulex has shelved its planned initial public offering (IPO), citing poor market conditions. The Alameda, California company initially filed for the IPO with the US Securities and Exchange Commission on 28 September but since then the path to becoming a publicly-listed company has been far from smooth: it later reduced the amount it was looking to raise from $86 million to $74 million (www.clinica.co.uk, 25 October 2012) then, in November, postponed the IPO. Singulex had planned to list under the ticker symbol SGLX.